Single vaccine dose shows 84% effectiveness against mpox, but insufficient for HIV patients
Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...
The American Journal of Managed Care8h
Presence of HIV Can Affect Treatment of Long COVID
Annie Antar, MD, PhD, discusses how patients with HIV can have different and longer-lasting symptoms of COVID-19.
Study shows significant progress in HIV treatment initiation in the Asia-Pacific region
In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the ...